Cargando…

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to...

Descripción completa

Detalles Bibliográficos
Autores principales: Karataş, Ayşe, İnkaya, Ahmet Çağkan, Demiroğlu, Haluk, Aksu, Salih, Haziyev, Tahmaz, Çınar, Olgu Erkin, Alp, Alpaslan, Uzun, Ömrüm, Sayınalp, Nilgün, Göker, Hakan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333597/
https://www.ncbi.nlm.nih.gov/pubmed/32694044
http://dx.doi.org/10.1016/j.transci.2020.102871
_version_ 1783553786973782016
author Karataş, Ayşe
İnkaya, Ahmet Çağkan
Demiroğlu, Haluk
Aksu, Salih
Haziyev, Tahmaz
Çınar, Olgu Erkin
Alp, Alpaslan
Uzun, Ömrüm
Sayınalp, Nilgün
Göker, Hakan
author_facet Karataş, Ayşe
İnkaya, Ahmet Çağkan
Demiroğlu, Haluk
Aksu, Salih
Haziyev, Tahmaz
Çınar, Olgu Erkin
Alp, Alpaslan
Uzun, Ömrüm
Sayınalp, Nilgün
Göker, Hakan
author_sort Karataş, Ayşe
collection PubMed
description Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to 63 days. A case whose viral shedding lasted 60 days is reported from China. Herein we report a patient with a history of autologous stem cell transplantation (ASCT) for lymphoma whose RT-PCR test remained positive for SARS-CoV-2 for 74 days. The prolonged RT-PCR positivity, despite convalescent plasma infusion, may suggest that the given antibodies may be ineffective in terms of viral clearance. In patients with hematological malignancies or immunosuppression, such as ASCT, may lead to prolonged viral shedding, and strict isolation is warranted for long-term SARS-CoV-2 infection control.
format Online
Article
Text
id pubmed-7333597
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73335972020-07-06 Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma Karataş, Ayşe İnkaya, Ahmet Çağkan Demiroğlu, Haluk Aksu, Salih Haziyev, Tahmaz Çınar, Olgu Erkin Alp, Alpaslan Uzun, Ömrüm Sayınalp, Nilgün Göker, Hakan Transfus Apher Sci Case Report Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first identified in Wuhan, China; and spread all over the world. Reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 usually returns to negative in 20 days post-infection, but prolonged positivity has been reported up to 63 days. A case whose viral shedding lasted 60 days is reported from China. Herein we report a patient with a history of autologous stem cell transplantation (ASCT) for lymphoma whose RT-PCR test remained positive for SARS-CoV-2 for 74 days. The prolonged RT-PCR positivity, despite convalescent plasma infusion, may suggest that the given antibodies may be ineffective in terms of viral clearance. In patients with hematological malignancies or immunosuppression, such as ASCT, may lead to prolonged viral shedding, and strict isolation is warranted for long-term SARS-CoV-2 infection control. Elsevier Ltd. 2020-10 2020-07-03 /pmc/articles/PMC7333597/ /pubmed/32694044 http://dx.doi.org/10.1016/j.transci.2020.102871 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Case Report
Karataş, Ayşe
İnkaya, Ahmet Çağkan
Demiroğlu, Haluk
Aksu, Salih
Haziyev, Tahmaz
Çınar, Olgu Erkin
Alp, Alpaslan
Uzun, Ömrüm
Sayınalp, Nilgün
Göker, Hakan
Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
title Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
title_full Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
title_fullStr Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
title_full_unstemmed Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
title_short Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
title_sort prolonged viral shedding in a lymphoma patient with covid-19 infection receiving convalescent plasma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333597/
https://www.ncbi.nlm.nih.gov/pubmed/32694044
http://dx.doi.org/10.1016/j.transci.2020.102871
work_keys_str_mv AT karatasayse prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT inkayaahmetcagkan prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT demirogluhaluk prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT aksusalih prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT haziyevtahmaz prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT cınarolguerkin prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT alpalpaslan prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT uzunomrum prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT sayınalpnilgun prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma
AT gokerhakan prolongedviralsheddinginalymphomapatientwithcovid19infectionreceivingconvalescentplasma